National framework on TB-Tobacco collaborative activities: most cost-effective way to manage TB-Tobacco comorbidity and extend tobacco cessation servcies
More details
Hide details
1
International Union Against Tuberculosis and Lung Disease, Tobacco Control, India
2
Ministry of Health and Family Welfare, Government of India, Directorate General of Health Services, India
Publication date: 2018-03-01
Tob. Induc. Dis. 2018;16(Suppl 1):A829
Download abstract book (PDF)
KEYWORDS
TOPICS
ABSTRACT
Background and challenges to implementation:
India, globally, has two disreputable distinctions
of having the highest TB burden in the world with 2.8M incidence / year (Global
Tuberculosis Report 2016) and also housing 2nd largest tobacco consumer with 267
million tobacco users.
Several
studies have documented that tobacco consumption may contribute to TB transmission
by transforming a dormant infection into active and more infectious disease,
can complicate the success of TB treatment, and can increase TB mortality rates.
India is implementing two national health
programmes to control TB and Tobacco i.e. Revise National Tuberculosis Control
Programme (RNTCP) and National Tobacco Control Programme (NTCP). It is important
to integrate these two to reduce comorbidity by collaborative activities.
Intervention or response:
In 2010, RNTCP
and NTCP with in collaboration with The Union piloted an intervention of
introducing brief advice on tobacco cessation during treatment of TB patients
in Vadodara district of Gujarat. The results of were encouraging. Subsequently
a working group was formed with representatives of RNTCP, NTCP WHO-India and
The Union to develop collaborative framework for TB and other co-morbidity and implementing
the same to cover the entire country.
Results and lessons learnt:
In the leadership of the Ministry
of Health & Family Welfare, the national framework on TB-Tobacco collaborative
activities was developed and released in a national level event. This is to be
followed by series of training of work force involved in both the programmes.
Conclusions and key recommendations:
RNTCP will be benefited by this collaboration to manage the comorbidity due to tobacco
use among TB patients. This also leverages the robust programme structure of RNTCP to extend brief
advice on tobacco quitting without any further investment.